As a non-traded REIT, Healthcare Trust operates with limited liquidity and transparency compared to exchange-traded peers. The company has faced significant portfolio challenges, with net asset value (NAV) declining from the original $25 per share to approximately $14.50–$15 per share as of April 2022, reflecting broader pressures in healthcare real estate markets.
Cyborg Score Rationale
The company faces substantial headwinds including NAV depreciation, limited liquidity for investors in a non-traded structure, and restricted growth opportunities due to closure of new investor offerings. Data availability is sparse, and the REIT has not demonstrated recent operational momentum.
Top Insights
Non-traded REIT structure with closed fundraising limits shareholder liquidity and exit opportunities
NAV per share declined from $25 (original) to $14.50–$15 (April 2022), representing significant value erosion
Portfolio focused on medical office buildings and seniors housing—sectors vulnerable to operational and occupancy pressures
Limited recent public disclosures and investor communication indicate operational stagnation or management focus on stabilization
Named Competitors
Healthcare Realty Trust — Publicly traded REIT owning 579 medical office properties across 28 states
Omega Healthcare Investors — Large-cap healthcare REIT focused on seniors housing and medical facilities
Sabra Health Care REIT — Healthcare REIT with diversified portfolio of seniors housing and medical office
Recent Developments
(December 2017) Acquired assets from affiliate American Realty Capital Healthcare Trust III for $120 million
(April 2022) Board updated NAV valuation to $14.50–$15 per share, marking continued decline from original offering price
Open the full interactive Healthcare Trust, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.